Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Toward a statistically relevant calibration end point for prostate seed implants.

D P Rosenzweig1, M C Schell, Y Yu

  • 1Department of Radiation Oncology, University of Rochester Medical Center, New York 14642, USA. rosenrosen@usa.net

Medical Physics
|February 5, 2000
PubMed
Summary

Radioactive seed strength variability has minimal impact on prostate brachytherapy dose delivery. Current guidelines on seed variability are likely too strict for prostate seed implants, suggesting a need for reevaluation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Optimal marker placement in photogrammetry patient positioning system.

Medical physics·2003
Same author

Dose broadening due to target position variability during fractionated breath-held radiation therapy.

Medical physics·2002
Same author

Solid-phase synthesis of 1,7-disubstituted-1,3,5-triazepane-2,4-diones.

Organic letters·2001
Same author

Time-resolved measurement of dissipation-induced decoherence in a Josephson junction.

Science (New York, N.Y.)·2001
Same author

Interactions between organic flocculant PAN-DCD and dyes.

Chemosphere·2001
Same author

Direct identification of a major autophosphorylation site on vascular endothelial growth factor receptor Flt-1 that mediates phosphatidylinositol 3'-kinase binding.

The Biochemical journal·2001

Area of Science:

  • Medical Physics
  • Oncology
  • Radiation Therapy

Background:

  • Interstitial brachytherapy for prostate cancer uses radioactive seeds for precise dose delivery.
  • Accurate dosimetry relies on both seed placement and consistent seed strength.
  • Variability in individual seed strengths can affect the delivered radiation dose.

Purpose of the Study:

  • To quantify the dose reduction caused by seed strength variability in prostate brachytherapy.
  • To assess the impact of seed strength variability on the minimum peripheral dose (mPD).
  • To evaluate the stringency of current AAPM guidelines for prostate seed implantation.

Main Methods:

  • Statistical analysis of dose reduction due to seed strength variability.
  • Focus on the independence of seed placement and seed strength issues.

Related Experiment Videos

  • Calculation of mPD reduction under varying seed strength conditions.

    • Main Results:

    • Seed strength variability causes a <0.4% reduction in mPD for average prostate configurations.
    • The maximum observed reduction in mPD was <1.5%.
    • This reduction is significantly lower than overall accuracy recommendations (e.g., AAPM TG 40).

    Conclusions:

    • Seed strength variability is a minor concern in prostate brachytherapy.
    • Current AAPM guidelines on seed-to-seed variability may be overly stringent for prostate applications.
    • Reevaluation of constraints on seed strength variability is warranted.